CSPC Pharmaceutical Group Limited

Company Profile

CSPC Pharmaceutical Group Limited had its IPO on under the ticker symbol CSPCY.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. CSPC Pharmaceutical Group Limited has a staff strength of 24,837 employees.

Stock update

Shares of CSPC Pharmaceutical Group Limited opened at $2.88 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.83 - $2.93, and closed at $2.88.

This is a +2.49% increase from the previous day's closing price.

A total volume of 76,762 shares were traded at the close of the day’s session.

In the last one week, shares of CSPC Pharmaceutical Group Limited have slipped by -1.96%.

CSPC Pharmaceutical Group Limited's Key Ratios

CSPC Pharmaceutical Group Limited has a market cap of $10.20 billion, indicating a price to book ratio of 3.187 and a price to sales ratio of 0.4253.

In the last 12-months CSPC Pharmaceutical Group Limited’s revenue was $30.94 billion with a gross profit of $21.14 billion and an EBITDA of $7.61 billion. The EBITDA ratio measures CSPC Pharmaceutical Group Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CSPC Pharmaceutical Group Limited’s operating margin was 0% while its return on assets stood at 11.04% with a return of equity of 21.32%.

In Q1, CSPC Pharmaceutical Group Limited’s quarterly earnings growth was a positive 28.2% while revenue growth was a positive 3%.

CSPC Pharmaceutical Group Limited’s PE and PEG Ratio

Forward PE

13.459

Trailing PE

11.6552

PEG

2.3783

Its diluted EPS in the last 12-months stands at $0.29 per share while it has a forward price to earnings multiple of 13.459 and a PEG multiple of 2.3783. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CSPC Pharmaceutical Group Limited’s profitability.

CSPC Pharmaceutical Group Limited stock is trading at a EV to sales ratio of 0.3774 and a EV to EBITDA ratio of 1.6182. Its price to sales ratio in the trailing 12-months stood at 0.4253.

CSPC Pharmaceutical Group Limited stock pays annual dividends of $0 per share, indicating a yield of 3.14% and a payout ratio of 34.23%.

Balance sheet and cash flow metrics

Total Assets

$41.77 billion

Total Liabilities

$8.96 billion

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

34.23%

CSPC Pharmaceutical Group Limited ended 2024 with $41.77 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $41.77 billion while shareholder equity stood at $30.20 billion.

CSPC Pharmaceutical Group Limited ended 2024 with $0 in deferred long-term liabilities, $8.96 billion in other current liabilities, in common stock, $21.14 billion in retained earnings and $234.90 million in goodwill. Its cash balance stood at $10.30 billion and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $28.95 million.

CSPC Pharmaceutical Group Limited’s total current assets stands at $23.96 billion while long-term investments were $0 and short-term investments were $3.57 billion. Its net receivables were $3.94 billion compared to accounts payable of $2.01 billion and inventory worth $2.55 billion.

In 2024, CSPC Pharmaceutical Group Limited's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, CSPC Pharmaceutical Group Limited paid $0.34 in dividends in 2024.

Other key metrics

Current Trading Price

$2.88

52-Week High

$5.2626

52-Week Low

$3.3051

Analyst Target Price

$

CSPC Pharmaceutical Group Limited stock is currently trading at $2.88 per share. It touched a 52-week high of $5.2626 and a 52-week low of $5.2626. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $3.04 and 200-day moving average was $3.76 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 3% are held by institutions.